2026/2027 | NCMP Practice Test | Complete Solution
Included | Pass Guaranteed - A+ Graded
Section 1: Menopause Physiology & Staging (STRAW+10 Criteria) (Q1-18)
Q1. A 48-year-old patient reports irregular menstrual cycles over the past 8 months,
with cycles varying from 21 to 45 days. Her FSH is 28 IU/L and estradiol is 65 pg/mL.
According to STRAW+10 staging criteria, which stage best describes her menopausal
status?
A. Late reproductive stage
B. Early menopausal transition [CORRECT]
C. Late menopausal transition
D. Early postmenopause
Rationale: STRAW+10 defines early menopausal transition as increased variability in
cycle length (>7 days difference from normal) with elevated FSH and normal-to-low
estradiol. Late reproductive stage (A) has regular cycles. Late transition (C) is
characterized by amenorrhea >60 days. Early postmenopause (D) is after 12 months
of amenorrhea.
Correct Answer: B
Q2. A 52-year-old patient has not had a menstrual period for 14 months. Her FSH is
85 IU/L and estradiol is 12 pg/mL. According to STRAW+10, which stage is she in?
A. Late menopausal transition
B. Early postmenopause [CORRECT]
C. Late postmenopause
D. Perimenopause
,Rationale: Early postmenopause is defined as the first 6 years after the final
menstrual period (FMP), with FSH >40 IU/L and estradiol <20 pg/mL. Late transition
(A) has amenorrhea <12 months. Late postmenopause (C) begins >6 years after FMP.
D is a broader term encompassing transition.
Correct Answer: B
Q3. The hallmark endocrine change of the menopausal transition is:
A. Sudden cessation of all ovarian hormone production
B. Declining ovarian follicle reserve with erratic estradiol and rising FSH [CORRECT]
C. Consistent elevation of inhibin B
D. Stable progesterone levels throughout the transition
Rationale: The menopausal transition is characterized by declining follicle reserve,
erratic estradiol fluctuations (not steady decline), and rising FSH due to loss of
negative feedback. A is incorrect as ovarian function declines gradually. C is wrong as
inhibin B falls. D is incorrect as progesterone becomes erratic.
Correct Answer: B
Q4. A 45-year-old patient presents with hot flashes and irregular periods. Her FSH is
15 IU/L on day 3 of her cycle. How should the clinician interpret this result?
A. She is definitively postmenopausal
B. She is in the late reproductive stage or early transition; a single FSH is insufficient
for staging [CORRECT]
C. She has primary ovarian insufficiency
D. Her ovarian function is completely normal
Rationale: A single FSH measurement during the menopausal transition is unreliable
due to erratic fluctuations. Values can vary significantly cycle to cycle. Staging
,requires clinical context and often serial measurements. A is incorrect as FSH <25 is
not postmenopausal. C requires FSH >40 + amenorrhea. D is incorrect given
symptoms.
Correct Answer: B
Q5. Which of the following best defines "perimenopause" according to NAMS and
STRAW+10 terminology?
A. The 12 months following the final menstrual period
B. The entire menopausal transition period from onset of cycle irregularity through
12 months after the FMP [CORRECT]
C. Only the late menopausal transition stage
D. The period beginning 5 years before menopause
Rationale: Perimenopause encompasses the entire transition from onset of cycle
changes through 12 months after the FMP. A defines early postmenopause. C is too
narrow. D is an arbitrary timeframe not used in staging systems.
Correct Answer: B
Q6. A 50-year-old patient with regular cycles has an SHBG of 180 nmol/L (high-
normal). She is considering oral hormone therapy. What is the clinical significance?
A. She should avoid all hormone therapy
B. Oral estrogen will further increase SHBG, potentially affecting bioavailability of
other hormones and thyroid [CORRECT]
C. Transdermal estrogen is contraindicated
D. High SHBG indicates liver disease
Rationale: Oral estrogen increases SHBG through first-pass hepatic metabolism,
affecting bioavailable testosterone and thyroid hormones. Transdermal estrogen (B)
, bypasses first-pass effect. A is incorrect. C is wrong as transdermal is preferred with
high SHBG. D is not indicated without other liver abnormalities.
Correct Answer: B
Q7. Which hormone is the most sensitive early marker of declining ovarian reserve
during the menopausal transition?
A. FSH
B. Inhibin B [CORRECT]
C. Estradiol
D. Progesterone
Rationale: Inhibin B, produced by granulosa cells, declines early as follicle reserve
decreases, preceding FSH elevation. FSH (A) rises later as negative feedback weakens.
Estradiol (C) fluctuates erratically. Progesterone (D) reflects corpus luteum function.
Correct Answer: B
Q8. A 55-year-old patient is 8 years post-FMP. She reports persistent hot flashes and
vaginal dryness. According to STRAW+10, which stage is she in?
A. Early postmenopause
B. Late postmenopause [CORRECT]
C. Perimenopause
D. Late menopausal transition
Rationale: Late postmenopause begins 6 years after the FMP and continues through
the remainder of life. Early postmenopause (A) is the first 6 years. C and D are pre-
menopausal stages.
Correct Answer: B